Literature DB >> 22537382

Fertility treatment when the prognosis is very poor or futile: a committee opinion.

.   

Abstract

The Ethics Committee recommends development of evidence-based policies that are patient-centered for each in vitro fertilization (IVF) center. In most cases, the provision of futile therapies is not ethically justifiable. For those treatments with very poor success rates, clinicians must be vigilant in their presentation of risks, benefits, and alternatives. This document was reviewed in January 2012. This version replaces the previous version of this document, published in 2009.
Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22537382     DOI: 10.1016/j.fertnstert.2012.03.045

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

1.  Treatment and preservation at the extremes of reproductive age: a case report outlining the ethical dilemmas.

Authors:  James D M Nicopoullos; Marie Wren; Hossam Abdalla
Journal:  J Assist Reprod Genet       Date:  2015-08-29       Impact factor: 3.412

2.  How Infertility Patients and Providers View and Confront Religious and Spiritual Issues.

Authors:  Robert Klitzman
Journal:  J Relig Health       Date:  2018-02

3.  The dilemma of counseling patients about poor prognosis: live birth after IVF with autologous oocytes in a 43-year-old woman with FSH levels above 30 mIU/mL.

Authors:  Heather R Burks; Marsha Baker; Alexander M Quaas; Kristin A Bendikson; Karine Chung; Richard J Paulson
Journal:  J Assist Reprod Genet       Date:  2017-06-27       Impact factor: 3.412

4.  When is clomiphene or gonadotropin intrauterine insemination futile? Results of the Fast Track and Standard Treatment Trial and the Forty and Over Treatment Trial, two prospective randomized controlled trials.

Authors:  Daniel J Kaser; Marlene B Goldman; June L Fung; Michael M Alper; Richard H Reindollar
Journal:  Fertil Steril       Date:  2014-09-16       Impact factor: 7.329

5.  Premature ovarian insufficiency patients with viable embryos derived from autologous oocytes through repeated oocyte retrievals could obtain reasonable cumulative pregnancy outcomes following frozen-embryo transfer.

Authors:  Xiuxian Zhu; Jing Ye; Yonglun Fu
Journal:  Ann Transl Med       Date:  2021-04

6.  Clinical vignettes and global health considerations of infertility care in under-resourced patients.

Authors:  Erika Tiffanie Chow; Shruthi Mahalingaiah
Journal:  Fertil Res Pract       Date:  2016-03-02

Review 7.  Mid-life fertility: Challenges & policy planning.

Authors:  Umesh N Jindal
Journal:  Indian J Med Res       Date:  2018-12       Impact factor: 2.375

8.  Predictive Factors for Live Birth in Autologous in Vitro Fertilization Cycles in Women Aged 40 Years and Older.

Authors:  Milan Reljič; Vida Gavrić Lovrec
Journal:  Zdr Varst       Date:  2019-10-01

9.  The "graying" of infertility services: an impending revolution nobody is ready for.

Authors:  Norbert Gleicher; Vitaly A Kushnir; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2014-07-09       Impact factor: 5.211

10.  Definition by FSH, AMH and embryo numbers of good-, intermediate- and poor-prognosis patients suggests previously unknown IVF outcome-determining factor associated with AMH.

Authors:  Norbert Gleicher; Vitaly A Kushnir; Aritro Sen; Sarah K Darmon; Andrea Weghofer; Yan-Guang Wu; Qi Wang; Lin Zhang; David F Albertini; David H Barad
Journal:  J Transl Med       Date:  2016-06-10       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.